847952-40-3

Basic information

• Product Name: L-Proline, N-[(phenylmethoxy)carbonyl]glycyl-2-methyl-, methyl ester
• CAS NO: 847952-40-3
• Molecular Formula: C17H22N2O5
• Molecular Weight: 334.372
• Mol File: 847952-40-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: L-Proline, N-[(phenylmethoxy)carbonyl]glycyl-2-methyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Proline, N-[(phenylmethoxy)carbonyl]glycyl-2-methyl-, methyl ester(847952-40-3)
• EPA Substance Registry System: L-Proline, N-[(phenylmethoxy)carbonyl]glycyl-2-methyl-, methyl ester(847952-40-3)

Safety Data

• Hazardous Substances Data: 847952-40-3(Hazardous Substances Data)

Upstream product

• 1138-80-3 N-(Benzyloxycarbonyl)glycine 
• 109837-32-3 methyl (S)-2-methylpyrrolidine-2-carboxylate 
• 538-75-0 dicyclohexyl-carbodiimide 
• 42856-71-3 (S)-2-methylpyrrolidine-2-carboxylic acid 
• 147-85-3 L-proline 
• 220200-88-4 (3R,7aS)-7a-methyl-3-(trichloromethyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one 
• 118916-60-2 (2R,5S)-2-trichloromethyl-1-aza-3-oxabicyclo[3.3.0]octan-4-one 
• 133010-18-1 Z-glycine fluoride 
• 220060-08-2 methyl (S)-2-methylpyrrolidine-2-carboxylate monohydrochloride 

Downstream Products

• 1261569-85-0 (S)-8a-methyloctahydropyrrolo[1,2-a]pyrazine 
• 847952-36-7 (8aS)-8a-methylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione 
• 869001-94-5 dibenzyl N-benzyloxycarbonyl-glycyl-L-2-methylprolyl-L-glutamate 
• 853400-76-7 glycyl-L-2-methylprolyl-L-glutamic acid 
• 869001-86-5 N-benzyloxycarbonyl-glycyl-L-2-methylproline 

Relevant articles and documents

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

Embodiments of this invention provide compounds, compositions, methods, and uses for therapeutic diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat Pitt Hopkins Syndrome and symptoms thereof, as well a

1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS

The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID

This invention provides compounds, compositions and methods for treating Autism Spectrum Disorders (ASD) using glycyl-2-methyIprolyl-glutamic acid (G-2-MePE) and analogs thereof. Autism Spectrum Disorders include Autism, Autistic Disorder, Asperger Syndro